Skip to main content
Journal of Assisted Reproduction and Genetics logoLink to Journal of Assisted Reproduction and Genetics
. 2012 May 30;29(8):803–810. doi: 10.1007/s10815-012-9799-6

The effect of immature oocytes quantity on the rates of oocytes maturity and morphology, fertilization, and embryo development in ICSI cycles

Iman Halvaei 1, Mohammad Ali Khalili 1,, Mohammad Hossein Razi 1, Stefania A Nottola 2
PMCID: PMC3430773  PMID: 22644633

Abstract

Purpose

The goal was to evaluate the role of the number of retrieved immature oocytes on mature oocyte counts and morphology, and also the rates of fertilization and embryo development in ICSI cycles.

Methods

101 ICSI cycles were included in this prospective evaluation. Patients were divided into 2 groups of A (≤ 2 immature oocytes) and B (> 2 immature oocytes). In sub-analysis, the impacts of the number of GV and MI oocytes were assessed on the rates of fertilization and embryo development. Also, correlations between the numbers of immature and mature oocytes, as well as maternal age between two groups were analyzed. Assessments of oocyte morphology, fertilization, embryo quality and development were done accordingly.

Results

There was no correlation between the immature oocytes quantity with the number of mature ones. There were insignificant differences for embryo development between two groups, but fertilization rate was higher in group A (P = 0.03). In sub-analysis, insignificant differences were observed between two groups of ≤ and >2 GV and MI oocytes for rates of fertilization and embryo development. Also, the rates of clinical pregnancy and delivery were insignificant between groups. The rate of morphologically abnormal oocytes had no significant difference between two groups, except for wide perivitelline space (PVS) which was higher in group A (P = 0.03). There was no significant difference for maternal age between two groups.

Conclusions

In cases with few retrieved immature oocytes, rates of fertilization and incidence of wide PVS may increase, although immature oocytes may not have any negative impacts on early embryo development, or the rates on number of mature oocytes.

Keywords: Immature oocytes, Oocyte morphology, Fertilization rate, Embryo quality, ICSI

Introduction

Introduction of intracytoplasmic sperm injection (ICSI) was a great achievement to give the opportunity of having babies primarily for couples with male factor infertility [25]. In ART, controlled ovarian hyperstimulation (COH) is necessary for inducing the recruitment of multiple follicular development for harvesting the numerous healthy mature oocytes. In recent years, several COH protocols have been introduced to optimize the ICSI outcomes. Despite optimizing the COH protocols, approximately 20 % of the oocytes remain immature at the GV or MI stages [26].

One of the factors that may affect the ICSI outcomes is related to the number of retrieved oocytes [20,37]. In addition, the maturity of retrieved oocytes is important for the success of in vitro fertilization, because mature oocytes are used for ART; while, the remaining immature ones are generally discarded. Although, it is possible to mature these oocytes using in-vitro maturation (IVM) technology, but both pregnancy and implantation rates have been reported very rare [19,24]. In recent years, some investigators tried to find some predictive values for the number of retrieved immature oocytes in COH program administered for ART outcomes [14]. There are some predictors for the number of retrieved immature oocytes, such as the number of 2 to 6-mm antral follicles, ovarian volume and peak ovarian stromal blood flow velocity measured by doppler ultrasound during the follicular phase. Also, there have been direct relations between the number of immature oocytes and pregnancy rates following IVM of human oocytes [4,13,31]. However, there are no strict data about the probable impact of these immature oocytes on maturity and outcome of their mature cohort oocytes in ART program. It seems that the effect(s) of immature oocyte quantity on ICSI outcomes are scarce. Therefore, this study was designed to evaluate the role of the number of retrieved immature oocytes on the mature oocyte count, morphology, rates of fertilization and embryo development in ICSI cases.

Materials and methods

Patient selection

A total of 101 ICSI cycles with male factor infertility were included in this prospective study. The female age was between 19–44 years old (mean 31.6 ± 0.2). Egg donation, natural cycles and IVM cases were excluded from the study. This study was approved by our institution ethics committee (number: 3706). For COH, the long protocol was used with GnRH agonist down-regulation, followed by rFSH (Gonal-F; Serono, Switzerland). The ovarian response was controlled by transvaginal ultrasound and serum estradiol concentration on the day of hCG injection. When diameter of at least two follicles was larger than 18 mm, 10,000 IU of hCG (i.m.; Profasi, Serono) was administered. Oocyte pick-up was performed 34–36 h after hCG injection under transvaginal ultrasound-guidance. All follicles larger than 14 mm were subjected to pick-up, while follicles smaller than 14 mm were not punctured. There was uniformity of the ultrasound measurements between our physicians.

Categorization of the immature oocytes

According to the number of immature oocytes, cycles were divided into two groups of A (≤ 2 immature oocytes) and B (>2 immature oocytes). Then, rates of fertilization and development of embryos were compared between two groups. In the sub-analysis, the impacts of the number of GV and MI oocytes were assessed on the rates of fertilization and embryo development. Also, the effect of maternal age on the quantity of immature oocyte was assessed.

ICSI procedure

Analysis of semen was performed according to WHO manual [33]. For sperm count and motility, Makler chamber and phase contrast microscopy were used. Percentages of progressive and non-progressive spermatozoa were reported. Sperm morphology was evaluated with Geimsa staining. Sperm preparation was performed using the swim-up or density gradient techniques as described previously [15]. ICSI procedure was described elsewhere in details [10]. Before the microinjection, evaluation of the maturity and morphology of the oocytes was done using inverted microscope (Nikon TE300, Japan). At the time of ICSI, none of the immature oocytes reached to MII stage. Therefore, they were discarded. Our policy is to microinject only the MII oocytes. The injected oocytes were washed twice, then put in fresh droplets of G1 (Vitrolife co., Sweden) covered with mineral oil (Reploline co., Germany). Degenerated oocytes after microinjection were excluded from the study.

Fertilization and embryo assessments

16–18 h post ICSI, the injected oocytes were checked for presence of the two pronuclei (2PN) and two polar bodies. Fertilization rates were calculated by 2PN no./ MII oocytes no. (%). Unfertilized oocytes were incubated longer and checked again. On day 2, cleaved embryos were evaluated under microscope as reported by [11]. Briefly, embryos were graded as follow: Grade A: equal size blastomeres without fragmentation, Grade B: slightly unequal blastomere, up to 10 % cytoplasmic fragments. Grade C: unequal sized blastomeres up to 50 % fragments and large granules. Grade D: unequal blastomeres with significant fragmentation and large black granules. Grade D embryos were not transferred.

Statistical analysis

Data were shown as mean ± S.E. The chi-square and fisher`s exact tests were used for statistical analysis. Independent samples t-test was used wherever appropriate. Also, data were presented as odds ratio (OR), 95 % confidence interval (95 % CI). The ORs refer to the fertilization rate, good quality or early cleaved embryos. Linear (Pearson) correlation test was applied to find the correlation between the number of immature and mature oocytes. P-value <0.05 was considered significant.

Results

The numbers of retrieved immature oocytes were between 0–8 and the average number was 1.26 ± 0.07 per cycle. The mean number of oocytes retrieved and mature ones per cycle was 8.04 ± 0.48 and 6.82 ± 0.45, respectively. The rate of oocyte obtained per follicle was 69.96 % ± 1.42. The majority of cycles had less than 2 immature oocytes (82.1 %). Also, regarding the number of GV and MI oocytes, 90 % of cases had less than 2 GV oocytes and in 96 % of cases less than 2 MI oocytes were retrieved. Of all the retrieved oocytes, 85 % were mature, while, 9 % and 6 % were at GV and MI stages, respectively.

There was no correlation between the number of immature oocytes and the number of mature ones in each cycle (P = 0.99, coefficient of determination (r2) = 0.0000004, correlation coefficient (r) = −0.00065, CI 95 % = −0.28 to 0.15) (Fig. 1). From total of 320 embryos which were formed in group A, 210 embryos (65.6 %) were good quality embryos and also for cleavage rate, from 320 embryos in group A, 244 embryos were early cleaved. Although, the data showed an increasing trend for formation of good quality embryos in group A compared to group B (65.6 % Vs 58.7 %, respectively) and for early cleavage rate in group B compared to A (80.9 % Vs 76.2 %, respectively), but the difference was insignificant (Table 1).

Fig. 1.

Fig. 1

Correlation between the number of immature and mature oocytes in each cycle

Table 1.

Rates of fertilization, formation of good quality embryo, early cleaved embryo, pregnancy and delivery in two groups of patients

Group A (≤2 immature oocytes) Group B (>2 immature oocytes) Odds ratio (95 % CI) P-value
Number of cases 83 18
Number of MII oocytes 509 121
Fertilization rate (%) 320/509 (62.8) 63/121 (52) 1.56 (1.05–2.33) 0.03
Good quality embryos (%) 210/320 (65.6) 37/63 (58.7) 1.38 (0.79–2.38) 0.2
Early cleavage rate (%) 244/320 (76.2) 51/63 (80.9) 0.8 (0.41–1.5) 0.62
Clinical pregnancy (%) 19/83 (22.8) 5/18 (27.7) 0.77 (0.24–2.44) 0.76
Delivery rate (%) 11/83 (13.2) 5/18 (27.7) 0.39 (0.11–1.33) 0.15

CI confidence interval, MII metaphase II

Out of 509 mature oocytes in group A, 320 oocytes were fertilized (62.8 %) which was significantly higher compared to group B (Table 1). In sub-analysis, no significant differences were recorded between two groups of ≤ 2 and >2 GV oocytes for rates of fertilization (60.8 % and 60.6 %, respectively) and embryo development (Table 2). Also between two groups of ≤ 2 and >2 MI oocytes, fertilization rate and early embryo development were similar (Table 3). Furthermore, clinical pregnancy as well as delivery rate between different groups was insignificant (Tables 1, 2 and 3). The data also showed that there were no significant differences for the maternal age between two groups of A (31.82 ± 0.23) and B (31.08 ± 0.51). Nevertheless, there was significant positive correlation between retrieval of MI oocytes with maternal age (P = 0.008).

Table 2.

Rates of fertilization, formation of good quality embryo, early cleaved embryo, pregnancy and delivery according to the number of GV oocytes

≤2 GV oocytes >2 GV oocytes Odds ratio (95 % CI) P-value
Number of cases 91 10
Number of MII oocytes 569 61
Fertilization rate (%) 346/569 (60.8) 37/61 (60.6) 1 (0.58-1.72) 1
Good quality embryos (%) 228/346 (65.8) 19/37 (51.3) 1.8 (0.91-3.55) 0.1
Early cleavage rate (%) 266/346 (76.8) 29/37 (78.3) 0.89 (0.39-2.03) 1
Clinical pregnancy (%) 21/91 (23) 3/10 (30) 0.7 (0.16-2.94) 0.43
Delivery rate (%) 13/91 (14.2) 3/10 (30) 0.38 (0.08-1.69) 0.19

CI confidence interval, GV germinal vesicle, MII metaphase II

Table 3.

Rates of fertilization, formation of good quality embryo, early cleaved embryo, pregnancy and delivery according to the number of MI oocytes

≤2 MI oocytes >2 MI oocytes Odds ratio (95 % CI) P-value
Number of cases 97 4
Number of MII oocytes 596 34
Fertilization rate (%) 364/596 (61) 19/34 (55.8) 1.2 (0.62-2.49) 0.59
Good quality embryos (%) 235/364 (64.5) 12/19 (63.1) 1.04 (0.4-2.7) 1
Early cleavage rate (%) 284/364 (78) 11/19 (57.8) 2.5 (0.98-6.46) 0.056
Clinical pregnancy (%) 23/97 (23.7) 1/4 (25) 0.93 (0.09-9.4) 1
Delivery rate (%) 15/97 (15.4) 1/4 (25) 0.54 (0.05-5.63) 0.5

CI confidence interval, MI metaphase I, MII metaphase II

The data generated from this study showed that the higher abnormality in oocyte morphology was fragmented 1st pb (Table 4). Likewise, the rate of two oocyte dysmorphisms were higher in women aged over 35, wide PVS and debris in PVS (P = 0.004, OR = 0.54, 95%CI = 0.36-81 and P = 0.002, OR = 0.42, 95%CI = 0.25-.71, respectively). There was insignificant difference for the formation of other oocyte abnormalities (extracytoplasmic and intracytoplasmic) between two groups, except for wide PVS, which was higher in group A (P = 0.03, Table 5) (Fig. 2).

Table 4.

Percentage of normal oocyte and oocyte morphological abnormalities

Criteria Percentage Criteria Percentage
Normal 18.9 Dark 4.1
Fragmented 1 PB 39.7 Irregular ZP 2.4
Refractile body 30.3 Vacuole 1.6
Wide PVS 21.3 Irregular shape 1.4
Granulation 12.2 SERc 1
Debris in PVS 10.6 Small 1 PB 0.6
Central granulation 9 Huge 1 PB 0.5
Bull eye 7

PB polar body, PVS perivitelline space, ZP zona pellucida, SERc smooth endoplasmic reticulum cluster

Table 5.

Comparison of different oocyte dysmorphism between two groups of A (≤ 2 immature oocytes) and B (> 2immature oocytes)

Group A Group B Odds ratio (95 % CI) P Group A Group B Odds ratio (95 % CI) P
Refractile body 30.45 32.23 1.03 (0.67–1.59) NS Dark oocyte 3.73 5.78 0.63 (0.25–1.53) NS
Central granulation 9.23 8.26 1.12 (0.55–2.3) NS SERc 1.17 0.82 1.43 (0.17–12) NS
Granulation 13.16 8.26 1.68 (0.83–3.37) NS Irregular shape 1.17 2.47 0.46 (0.11–1.9) NS
Wide PVS 22.98 14.04 1.82 (1.05–3.17) 0.03 Vacuole 1.37 2.47 0.54 (0.14–2.15) NS
Bull eye 7.46 4.95 1.54 (0.63–3.74) NS Irregular ZP 2.94 0.82 3.64 (0.47–27) NS
Debris in PVS 11 9.09 1.23 (0.62–2.43) NS Small PB 0.58 0.82 0.17 (0.07–6.9) NS
Fragmented 1st PB 41.45 32.23 0.67 (0.44-1.02) NS Huge PB 0.19 1.65 0.11 (0.01-1.3) NS

Data are shown as percentage

PB polar body, PVS perivitelline space, ZP zona pellucida, SERc smooth endoplasmic reticulum cluster, NS not significant

Fig. 2.

Fig. 2

Different oocyte morphological criteria. a normal, b refractile body, c dark, d smooth endoplasmic reticulum cluster, e vacuole, f wide perivitelline space, g small polar body, h irregular zona pellucida, i irregular shape, j bull eye, k central granulation, l general granulation, m debris in periviteline space, n fragmented polar body, o huge polar body

Discussion

Many factors may affect the success rate of ICSI such as, maternal age [9], oocyte morphology [16,36], sperm quality [29], ICSI technique [3], injection pipette [30], ICSI operator [28], and quality of transferred embryos [12]. Our data showed that 15 % of retrieved oocytes remained immature. Therefore, to maximize the ICSI success rates, the number and quality of MII eggs in stimulated cycles are important. One of the influential instances maybe the number and the stage of immature oocytes in each cycle. However, the influential effects of immature oocytes on the quality and number of mature oocytes in ICSI are still unclear. Wittemer et al. [34] stated that fertilization rate is higher in IVF cycles with more than 10 % GV oocytes compared to cycles with less GV [34]. They inseminated all cumulus oocyte complexes (including GV, MI and MII) and compared the outcomes. In group with more than 10 % GV, they observed more oocytes with higher fertilization rate. Here, we used number 2 for GV as a cutoff value, and if we used another strategy for choosing cutoff value, we may have found different results. Moreover, Kok and associates showed that the degree of ovarian response and the fraction of immature oocytes may not affect ICSI fertilization rate [18].

Our data demonstrated that the number of immature oocytes may be useful for prognosis of ICSI fertilization outcome. Accordingly, if the number of immature oocytes was higher than two, the fertilization in cohort mature oocytes was significantly lower. This fact may be related to the possibility that, when immature oocytes are numerous at the pick-up, ovarian follicles may in general be less responsive to the ovarian stimulation. We hypothesize that oocytes collected during cycles with ≤2 immature oocytes have better maturational condition than oocytes retrieval during cycles with more than two immature oocytes. So optimizing the ovarian stimulation protocol to reach this goal is suggested. The data showed that the number of retrieved immature oocytes had no effect on the competence of cohort mature oocytes for good embryo formation. One of the important contributing factor for failed fertilization is the number of retrieved mature oocytes [7]. One probable reason for higher fertilization rate in group A may be due to the increase in the number of mature oocytes available for injection. COH has a key role in ART, and high doses of gonadotropins induce simultaneous growth and development of follicles. One of the causes that retrieved oocytes are in different stages of development is heterogeneity of follicles population at the time of hCG injection [17].

We found that 15 % of oocytes remained immature, which is similar to other report [32]. Some follicles have begun their development in previous cycles, while some are going to develop in this cycle. So, their response to supraphysiologic gonadotropins and their growth speed would be different. It is reported that follicles may have some effects on each other via paracrine secretion. Transforming growth factor-β operates via paracrine or autocrine mechanisms in order to regulate follicular development and oocyte maturation [1,8]. It is mentioned that anti-Mullerian hormone (AMH) inhibits the recruitment of primordial follicles via paracrine activity [6]. Nevertheless, when some oocytes remain immature, in spite of ovarian hyperstimulation, it may be due to the presence of intrinsic defects in the oocytes or even follicles. According to our hypothesis, these immature oocytes may have some negative impacts on the other healthy oocytes via paracrine secretion. Hence, the presence of MI/ GV oocytes after hyperstimulation was not shown to be related with poor outcomes on their mature cohort oocytes.

It is well known that advanced female age is well correlated with the poor quality of eggs. Our data showed that the chance of MI oocyte retrieval is increased in older women. One reason may be related to ovarian function which is decreased with advancing of age as well as the reduction of ovarian response to hyperstimulation. In addition, one of the most important steps in ART is to harvest healthy mature oocytes, which is related to ART success [21]. The findings also showed that the rate of wide PVS is higher in group A, as well as in older women. As mentioned before, we hypothesized that the immature oocytes may have some probable negative effect(s) on the cohort healthy mature oocytes. But, we did not notice any significant differences between rate of oocytes dysmorphism in two groups under investigation, except for wide PVS. Wide PVS may be seen because of overmaturity of cytoplasm at the time of hCG injection. So, PVS enlargement may be related to increased maternal age, and oocyte aging [22,35]. One study detected enlarged PVS as a sign of degeneration/postmaturity in unfertilized human oocytes from an ultrastructural point of view [23]. Also it is suggested that the extracytoplasmic dysmorphisms (e.g. wide PVS) should be considered only a phenotypic heterogeneity of the retrieved oocytes [2]. According to our data, in case of fewer retrieved immature oocytes, the expectation of observing abnormalities which are related to overmaturity may increase. In other words, advanced maternal age and immature oocytes retrieval <2, are two risk factors for these abnormalities. We did not find any significant differences between immature oocyte count and oocyte intracytoplasmic abnormalities. Nevertheless, no significant differences for cytoplasmic abnormalities between young and old women were observed in our population. The causes of cytoplasmic oocyte abnormalities may be multifactorial, for example ovarian stimulation and hormonal environment [27]. Recently, de Cassia et al. [5] showed that the number of retrieved oocytes significantly correlated with increasing incidence of cytoplasmic granularity [5]. They also reported that excessive ovarian response had negative effect on oocyte quality. In the present study, we tried to omit the effect of various ovarian stimulation protocols on oocyte quality, as the patients received long protocol for ovarian stimulation, but various ovarian response and intrinsic variations between the patients may be one reason for seeing these abnormalities. The cause of oocyte morphological abnormalities is probably multifactorial, so larger studies are in need to investigate the relationship between the probable effects of retrieved immature oocytes on feature of mature cohort oocytes.

In conclusion, in cases with few retrieved immature oocytes, the fertilization rates will increase, although it may not have any impacts on early embryo development, or their maturation rate. Besides, advanced maternal age is a risk factor for harvesting MI oocytes and wide PVS. Although, we did not find any negative impact of immature oocyte count on rates of pregnancy and delivery, but controlled studies with large sample size are necessary to elucidate the role of immature oocytes quantity on ART outcomes.

Acknowledgments

The authors appreciate Ms. Farimah Shamsi for her help in consulting for statistical analysis and Ms. Leila Motamedzadeh for her laboratory skill during the study.

Glossary

ICSI

Intracytoplasmic sperm injection

ART

Assisted reproductive technology

COH

Controlled ovarian hyperstimulation

GV

Germinal vesicle

MI

Metaphase I

IVM

In-vitro maturation

GnRH

Gonadotropin releasing hormone

rFSH

Recombinant follicle stimulating hormone

hCG

Human chorionic gonadotropin

mm

Millimeter

IU

International unit

im

Intramascular

h

Hour

OBGYN

Obstetric and gynecology

WHO

World health organization

2PN

Two pronuclei

SE

Standard error

OR

Odds ratio

CI

Confidence interval

PVS

Perivitteline space

MII

Metaphase II

AMH

Anti-Mullerian hormone

PB

Polar body

ZP

Zona pellucida

SERc

Smooth endoplasmic reticulum cluster

NS

Not significant

Footnotes

Capsule

In cases with less than two retrieved immature oocytes fertilization rate may increase in cohort oocytes but has no effect on early embryo development. Also there is no correlation between the number of immature and mature oocytes in each cycle.

Contributor Information

Iman Halvaei, Email: ihalvaei@gmail.com.

Mohammad Ali Khalili, Phone: +98-351-8247086, FAX: +98-351-8247086, Email: khalili59@hotmail.com.

References

  • 1.Baerwald AR, Adams GP, Pierson RA. Ovarian antral folliculogenesis during the human menstrual cycle: a review. Hum Reprod Update. 2012;18(1):73–91. doi: 10.1093/humupd/dmr039. [DOI] [PubMed] [Google Scholar]
  • 2.Balaban B, Urman B. Effect of oocyte morphology on embryo development and implantation. Reprod Biomed Online. 2006;12(5):608–615. doi: 10.1016/S1472-6483(10)61187-X. [DOI] [PubMed] [Google Scholar]
  • 3.Blake M, Garrisi J, Tomkin G, Cohen J. Sperm deposition site during ICSI affects fertilization and development. Fertil Steril. 2000;73(1):31–37. doi: 10.1016/S0015-0282(99)00465-3. [DOI] [PubMed] [Google Scholar]
  • 4.Child TJ, Sylvestre C, Pirwany I, Tan SL. Basal serum levels of FSH and estradiol in ovulatory and anovulatory women undergoing treatment by in-vitro maturation of immature oocytes. Hum Reprod. 2002;17(8):1997–2002. doi: 10.1093/humrep/17.8.1997. [DOI] [PubMed] [Google Scholar]
  • 5.Cassia SFR, Almeida Ferreira Braga DP, Semiao-Francisco L, Madaschi C, Iaconelli A, Jr, Borges E., Jr Metaphase II human oocyte morphology: contributing factors and effects on fertilization potential and embryo developmental ability in ICSI cycles. Fertil Steril. 2010;94(3):1115–1117. doi: 10.1016/j.fertnstert.2009.11.039. [DOI] [PubMed] [Google Scholar]
  • 6.Durlinger A, Visser JA, Themmen A. Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction. 2002;124(5):601–609. doi: 10.1530/rep.0.1240601. [DOI] [PubMed] [Google Scholar]
  • 7.Esfandiari N, Javed MH, Gotlieb L, Casper RF. Complete failed fertilization after intracytoplasmic sperm injection–analysis of 10 years' data. Int J Fertil Womens Med. 2005;50(4):187–192. [PubMed] [Google Scholar]
  • 8.Gougeon A. Human ovarian follicular development: from activation of resting follicles to preovulatory maturation. Ann Endocrinol (Paris) 2010;71(3):132–143. doi: 10.1016/j.ando.2010.02.021. [DOI] [PubMed] [Google Scholar]
  • 9.Halvaei I, Khalili MA, Soleimani M, Razi MH. Does maternal age have any effect on the rates of fertilization and embryo development in ICSI cycles? Iranian J Reprod Med. 2011;9(Suppl. 1):49. [Google Scholar]
  • 10.Halvaei I, Khalili MA, Soleimani M, Razi MH. Evaluating the role of first polar body morphology on rates of fertilization and embryo development in ICSI cycles. Int J Fertil Steril. 2011;5(2):110–115. [PMC free article] [PubMed] [Google Scholar]
  • 11.Hill GA, Freeman M, Bastias MC, Rogers BJ, Herbert CM, Osteen KG, Wentz AC. The influence of oocyte maturity and embryo quality on pregnancy rate in a program for in vitro fertilization-embryo transfer. Fertil Steril. 1989;52(5):801–806. doi: 10.1016/s0015-0282(16)61034-8. [DOI] [PubMed] [Google Scholar]
  • 12.Hsu M, Mayer J, Aronshon M, Lanzendorf S, Muasher S, Kolm P, Oehninger S. Embryo implantation in in vitro fertilization and intracytoplasmic sperm injection: impact of cleavage status, morphology grade, and number of embryos transferred. Fertil Steril. 1999;72(4):679–685. doi: 10.1016/S0015-0282(99)00320-9. [DOI] [PubMed] [Google Scholar]
  • 13.Jayaprakasan K, Deb S, Batcha M, Hopkisson J, Johnson I, Campbell B, Raine-Fenning N. The cohort of antral follicles measuring 2–6 mm reflects the quantitative status of ovarian reserve as assessed by serum levels of anti-Müllerian hormone and response to controlled ovarian stimulation. Fertil Steril. 2010;94(5):1775–1781. doi: 10.1016/j.fertnstert.2009.10.022. [DOI] [PubMed] [Google Scholar]
  • 14.Jee BC, Ku SY, Suh CS, Kim KC, Lee WD, Kim SH. Serum anti-Müllerian hormone and inhibin B levels at ovulation triggering day can predict the number of immature oocytes retrieved in in vitro fertilization cycles. J Korean Med Sci. 2008;23(4):657–661. doi: 10.3346/jkms.2008.23.4.657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Khalili MA, Mir-Rokni F, Kalantar SM. Application of vitality tests on asthenozoospermic semen from infertile men. Iran Biomed J. 1999;3:77–81. [Google Scholar]
  • 16.Khalili MA, Mojibian M, Sultan AM. Role of oocyte morphology on fertilization and embryo formation in assisted reproductive techniques. Middle East Fertil Soc J. 2005;10(1):72–77. [Google Scholar]
  • 17.Kim BK, Lee SC, Kim KJ, Han CH, Kim JH. In vitro maturation, fertilization, and development of human germinal vesicle oocytes collected from stimulated cycles. Fertil Steril. 2000;74(6):1153–1158. doi: 10.1016/S0015-0282(00)01617-4. [DOI] [PubMed] [Google Scholar]
  • 18.Kok JD, Looman CWN, Weima SM, Velde ER. A high number of oocytes obtained after ovarian hyperstimulation for in vitro fertilization or intracytoplasmic sperm injection is not associated with decreased pregnancy outcome. Fertil Steril. 2006;85(4):918–924. doi: 10.1016/j.fertnstert.2005.09.035. [DOI] [PubMed] [Google Scholar]
  • 19.Lin YH, Hwang JL. In vitro maturation of human oocytes. Taiwan J Obstet Gynecol. 2006;45(2):95–99. doi: 10.1016/S1028-4559(09)60204-7. [DOI] [PubMed] [Google Scholar]
  • 20.McAvey B, Zapantis A, Jindal SK, Lieman HJ, Polotsky AJ. How many eggs are needed to produce an assisted reproductive technology baby: is more always better? Fertil Steril. 2011;96(2):332–335. doi: 10.1016/j.fertnstert.2011.05.099. [DOI] [PubMed] [Google Scholar]
  • 21.Melie N, Adeniyi O, Igbineweka O, Ajayi R. Predictive value of the number of oocytes retrieved at ultrasound-directed follicular aspiration with regard to fertilization rates and pregnancy outcome in intracytoplasmic sperm injection treatment cycles. Fertil Steril. 2003;80(6):1376–1379. doi: 10.1016/S0015-0282(03)02213-1. [DOI] [PubMed] [Google Scholar]
  • 22.Miao Y, Ma S, Liu X, Miao D, Chang Z, Luo M, Tan J. Fate of the first polar bodies in mouse oocytes. Mol Reprod Dev. 2004;69(1):66–76. doi: 10.1002/mrd.20148. [DOI] [PubMed] [Google Scholar]
  • 23.Motta PM, Nottola SA, Micara G, Familiari G. Ultrastructure of human unfertilized oocytes and polyspermic embryos in an IVF–ET program a. Ann N Y Acad Sci. 1988;541(1):367–383. doi: 10.1111/j.1749-6632.1988.tb22274.x. [DOI] [PubMed] [Google Scholar]
  • 24.Nazari S, Khalili MA, Esmaielzadeh F, Mohsenzadeh M. Maturation capacity, morphology and morphometric assessment of human immature oocytes after vitrification and in-vitro maturation. Iranian J Reprod Med. 2011;9(3):209–216. [PMC free article] [PubMed] [Google Scholar]
  • 25.Palermo GD, Cohen J, Rosenwaks Z. Intracytoplasmic sperm injection: a powerful tool to overcome fertilization failure. Fertil Steril. 1996;65(5):899–908. doi: 10.1016/s0015-0282(16)58257-0. [DOI] [PubMed] [Google Scholar]
  • 26.Rienzi L, Ubaldi F, Anniballo R, Cerulo G, Greco E. Preincubation of human oocytes may improve fertilization and embryo quality after intracytoplasmic sperm injection. Hum Reprod. 1998;13(4):1014–1019. doi: 10.1093/humrep/13.4.1014. [DOI] [PubMed] [Google Scholar]
  • 27.Serhal PFRD, Kinis A, Marchant S, Davies M, Khadum IM. Oocyte morphology predicts outcome of intracytoplasmic sperm injection. Hum Reprod. 1997;12:1267–1270. doi: 10.1093/humrep/12.6.1267. [DOI] [PubMed] [Google Scholar]
  • 28.Shen S, Khabani A, Klein N, Battaglia D. Statistical analysis of factors affecting fertilization rates and clinical outcome associated with intracytoplasmic sperm injection. Fertil Steril. 2003;79(2):355–360. doi: 10.1016/S0015-0282(02)04675-7. [DOI] [PubMed] [Google Scholar]
  • 29.Strassburger D, Friedler S, Raziel A, Schachter M, Kasterstein E, Ron-El R. Very low sperm count affects the result of intracytoplasmic sperm injection. J Assist Reprod Genet. 2000;17(8):431–436. doi: 10.1023/A:1009413201849. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Svalander P, Forsberg A, Jakobsson A, Wikland M. Factors of importance for the establishment of a successful program of intracytoplasmic sperm injection treatment for male infertility. Fertil Steril. 1995;63(4):828–837. doi: 10.1016/s0015-0282(16)57489-5. [DOI] [PubMed] [Google Scholar]
  • 31.Tan SL, Child TJ, Gulekli B. In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography. Am J Obstet Gynecol. 2002;186(4):684–689. doi: 10.1067/mob.2002.122146. [DOI] [PubMed] [Google Scholar]
  • 32.Steirteghem AC, Liu J, Joris H, Nagy Z, Janssenswillen C, Tournaye H, Derde MP, Assche E, Devroey P. Higher success rate by intracytoplasmic sperm injection than by subzonal insemination. Report of a second series of 300 consecutive treatment cycles. Hum Reprod. 1993;8(7):1055–1060. doi: 10.1093/oxfordjournals.humrep.a138191. [DOI] [PubMed] [Google Scholar]
  • 33.WHO (2010) WHO laboratory manual for the Examination and processing of human semen. 5 edn. Cambridge University Press.
  • 34.Wittemer C, Ohl J, Bettahar-Lebugle K, Viville S, Nisand I. A quantitative and morphological analysis of oocytes collected during 438 IVF cycles. J Assist Reprod Genet. 2000;17(1):44–50. doi: 10.1023/A:1009402130903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Xia P. lntracytoplasmic sperm injection: correlation of oocyte grade based on polar body, perivitelline space and cytoplasmic inclusion with fertilization rate and embryo quality. Hum Reprod. 1997;2:1750–1755. doi: 10.1093/humrep/12.8.1750. [DOI] [PubMed] [Google Scholar]
  • 36.Xing X, Zhao H, Li M, Sun M, Li Y, Chen ZJ (2011) Morphologically abnormal oocytes not capable of fertilization despite repeated strategies. Fertility and Sterility 95 (7):2435 e2435-2437 [DOI] [PubMed]
  • 37.Yoldemir T, Fraser I. The effect of retrieved oocyte count on pregnancy outcomes in an assisted reproduction program. Arch Gynecol Obstet. 2010;281(3):551–556. doi: 10.1007/s00404-009-1221-y. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Assisted Reproduction and Genetics are provided here courtesy of Springer Science+Business Media, LLC

RESOURCES